Perioperative fluid therapy

Journal of the American Veterinary Medical Association

Volumn 221, Issue 8, 2002, Pages 1112-1121

  Kudnig, Simon T ^a   Mama, Khursheed ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; BLOOD PRESSURE MEASUREMENT; FLUID THERAPY; GENERAL ANESTHESIA; METHODOLOGY; PEROPERATIVE CARE; REVIEW; STANDARD;

ANESTHESIA, GENERAL; ANIMALS; BLOOD PRESSURE DETERMINATION; FLUID THERAPY; INTRAOPERATIVE CARE;

EID: 0037107665     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.2002.221.1112     Document Type: Article

References (121)

1. Ko JCH, Golder FJ, Mandsager RE, et al. Anesthetic and cardiorespiratory effects of a 1:1 mixture of propofol and thiopental sodium in dogs. J Am Vet Med Assoc 1999;215:1292-1296.
2. Mutoh T, Nishimura R, Kim HY, et al. Cardiopulmonary effects of sevoflurane, compared with halothane, enflurane, and isoflurane, in dogs. Am J Vet Res 1997;58:885-890.
3. Tomiyasu S, Hara T, Hasuo H, et al. Comparative analysis of systemic and coronary hemodynamics during sevoflurane-and isoflurane-induced hypotension in dogs. J Cardiovasc Pharmacol 1999;35:741-747.
4. Gelissen HPMM, Epema AH, Henning RH, et al. Inotropic effects of propofol, thiopental, midazolam, etomidate, and ketamine on isolated human atrial muscle. Anesthesiology 1996;84:397-403.
5. Cohen HJ, Marsh DJ, Kayser B. Autoregulation in vasa recta of the rat kidney. Am J Physiol 1983;245:F32-F40.
6. Moore LC, Casellas D. Tubuloglomerular feedback dependence of autoregulation in rat juxtamedullary afferent arterioles. Kidney Int 1990;37:1402-1408.
7. Divers TJ, Whitlock RH, Byars TD, et al. Acute renal failure in six horses resulting from haemodynamic causes. Equine Vet J 1987; 19:178-184.
8. Muzi M, Ebert TJ. A comparison of baroreflex sensitivity during isoflurane and desflurane anesthesia in humans Anesthesiology 1995;82:919-925.
9. Sellgren J, Ejnell H, Elam M, et al. Sympathetic muscle nerve activity, peripheral blood flows, and baroreceptor reflexes in humans during propofol anesthesia and surgery. Anesthesiology 1994;80:534-544.
10. 2 gradients as markers of intestinal ischaemia. Intensive Care Med 1998;24:599-604.
11. Gaynor JS, Dunlop CI, Wagner AE, et al. Complications and mortality associated with anesthesia in dogs and cats. J Am Anim Hosp Assoc 1999;35:13-17.
12. Campbell IT, Baxter JN, Tweedie IE, et al. IV fluids during surgery. Br J Anaesth 1990;65:726-729.
13. Fieldman NR, Forsling ML, LeQuesne LP. The effect of vasopressin on solute and water excretion during and after surgical operations. Ann Surg 1985;201:383-390.
14. Hauptman JG, Richter MA, Wood SL, el at. Effects of anesthesia, surgery and intravenous administration of fluids on plasma antidiuretic hormone concentrations in healthy dogs. Am J Vet Res 2000;61:1273-1276.
15. Burton S, Lemke KA, Ihle SL, et al. Effects of medetomidine on serum osmolality; urine volume, osmolality and pH; free water clearance; and fractional clearance of sodium, chloride, potassium, and glucose in dogs. Am J Vet Res 1998;59:756-761.
16. Mythen MG, Webb AR. Perioperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery. Arch Surg 1995;130:423-429.
17. Funk W, Baldinger V. Microcirculatory perfusion during volume therapy. A comparative study using crystalloid or colloid in awake animals. Anesthesiology 1995;82:975-982.
18. Hahn RG, Drobin D, Stahle L. Volume kinetics of Ringer's solution in female volunteers. Br J Anaesth 1997;78:144-148.
19. Vaupshas HJ, Levy M. Distribution of saline following acute volume loading: postural effects. Clin Invest Med 1990;13:165-177.
20. Mazzoni MC, Borgstrom P. Arfors KE, et al. Dynamic fluid redistribution in hyperosmotic resuscitation of hypovolemic hemorrhage. Am J Physiol 1988;255:H629-H637.
21. Smith GJ, Kramer GC, Perron P, et al. A comparison of several Hypertonic solutions for resuscitation of bled sheep. J Surg Res 1985;39:517-528.
22. Carey JS, Scharschmidt BF, Culliford AT, et al. Hemodynamic effectiveness of colloid and electrolyte solutions for replacement of simulated operative blood loss. Surg Gynecol Obstet 1970;131: 679-686.
23. Amundson B, Jennische E, Haljamae H. Skeletal muscle microcirculatory and cellular metabolic effects of whole blood, Ringer's lactate and dextran 70 infusions in hemorrhagic shock. Circ Shock 1980;7:111-120.
24. Morissette M, Weil MH, Shubin H. Reduction in colloid oncotic pressure associated with fatal progression of cardiopulmonary failure. Crit Care Med 1975;3:115-117.
25. Chan DL, Freeman LM, Rozanski EA, et al. Colloid osmotic pressure of parenteral nutrition components and intravenous fluids. J Vet Emerg Crit Care 2001;11:269-273.
26. DiBartola SP. Introduction to fluid therapy. In: DiBartola SP, ed. fluid therapy in small animal practice. 2nd ed. Philadelphia: WB Saunders Co, 2000;265-280.
27. Rudloff E, Kirby R. The critical need for colloids: selecting the right colloid. Comp Contin Educ Pract Vet 1997;19:811-826.
28. Tonnessen T, Tollofsrud S, Kongsgaard UE, et al. Colloid osmotic pressure of plasma replacement fluids. Acta Anaesthesiol Scand 1993;37:424-426.
29. Fisher MM, Brady PW. Adverse reactions to plasma volume expanders. Drug Saf 1990;5:86-93.
30. De Labarthe A, Jacobs F, Blot F, et al. Acute renal failure secondary to hydroxyethylstarch administration in a surgical patient. Am J Med 2001;111:417-418.
31. Rozich JD, Paul RV. Acute renal failure precipitated by elevated colloid osmotic pressure. Am J Med 1989;87:358-360.
32. Lazarchick J, Conroy JM. The effect of 6% hydroxyethyl starch and desmopressin infusion on von Willebrand lactor: ristocetin cofactor activity. Ann Clin Lab Sci 1995;25:306-309.
33. Thompson WL, Fukushima T, Rutherford RB, et al. Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch. Surg Gynecol Obstet 1970;131:965-972.
34. Concannon KT, Haskins SC, Feldman BF. Hemostatic defects associated with two infusion rates of dextran 70 in dogs. Am J Vet Res 1992;53:1369-1375.
35. Hedin H, Richter W. Pathomechanisms of dextran-induced anaphylactoid/anaphylactic reactions in man. Int Arch Allergy Immunol 1982;68:122-126.
36. Matheson NA, Diomi P. Renal failure after administration of dextran 40. Surg Gynecol Obstet 1970;131:661-668.
37. Broadstone RV. Fluid therapy and newer blood products. Vet Clin North Am Small Anim Pract 1999;29:611-628.
38. Mathews KA. The various types of parenteral fluids and their indications. Vet Clin North Am Small Anim Pract 1998;28: 483-513.
39. Rudloff E, Kirby R. The critical need for colloids: administering colloids effectively. Comp Contin Educ Pract Vet 1997;20:27-43.
40. Thurmann PA, Lissner R, Struff WG, et al. Pharmacokinetics of oxypolygelatine in healthy volunteers. Eur J Clin Pharmacol 1999; 55:49-51
41. Evans PA, Glenn JR, Heptinstall S, et al. Effects of gelatin-based resuscitation fluids on platelet aggregation. Br J Anaesth 1998; 81:198-202.
42. Egli GA, Zollinger A, Seifert B, et al. Effect of progressive haemodilution with hydroxyethyl starch, gelatin and albumin on blood coagulation. Br J Anaesth 1997;78:684-689.
43. Mortier E, Ongenae M, De Baerdemaeker L, et al. In vitro evaluation of profound haemodilution with hydroxyethyl starch 6%, modified fluid gelatin 4% and dextran 40 10% on coagulation profile measured by thromboelastography Anaesthesia 1997;52:1061-1064.
44. Moggio RA, Rha CC, Somberg ED, et al. Hemodynamic comparison of albumin and hydroxyethyl starch in postoperative cardiac surgery patients. Crit Care Med 1983;11:943-945.
45. Zikria BA, Subbarao C, Oz MC, et al. Macromolecules reduce abnormal microvascular permeability in rat limb ischemia-reperfusion injury. Crit Care Med 1989;17:1306-1309.
46. Sanfelippo MJ, Suberviola PD, Giemer NE Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch. Am J Clin Pathol 1987;88:653-655.
47. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomized study. Lancet 2001;357:911-916.
48. Smiley LE, Garvey MS. The use of hetastarch as adjunct therapy in 26 dogs with hypoalbuminemia: a phase two clinical trial. J Vet Intern Med 1994;8:195-202.
49. Strauss RG. Review of the effects of hydroxyethyl starch on the blood coagulation system. Transfusion 1981;21:299-302.
50. London MJ, Ho JS, Triedman JK, et al. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations. J Thorac Cardiovasc Surg 1989;97:785-797.
51. Strauss RG, Stansfield C, Henriksen RA, et al. Pentastarch may cause fewer effects on coagulation than hetastarch Transfusion 1988;28:257-260.
52. Khosropour R, Lackner F, Steinbereithner K, et al. Comparison of the effect of pre-and intra-operative administration of medium molecular weight hydroxyethyl starch (HES200/0.5) and dextran 40(60) in vascular surgery. Anaesthetist 1980;29:616-622.
53. Hardin TC, Page CP, Schwesinger WH. Rapid replacement of serum albumin in patients receiving total parenteral nutrition. Surg Gynecol Obstet 1986;163:359-362.
54. Garvey MS. Fluid and electrolyte balance in critical patients. Vet Clin North Am Small Anim Pract 1989;19:1021-1057.
55. Kirby R. Transfusion therapy in emergency and critical care medicine. Vet Clin North Am Small Anim Pract 1995;25:1365-1386.
56. Johnstone IB, Keen J, Halbert A, et al. Stability of factor VIII and von Willebrand factor in canine blood samples during storage. Can Vet J 1991;32:173-175.
57. Nilsson L, Hedner U, Nilsson IM, et al. Shelf-life of bank blood and stored plasma with special reference to coagulation factors. Transfusion 1983;23:377-381.
58. Preston AE. The factor-VIII activity in fresh and stored plasma. Br J Haematol 1967;13:42-59.
59. Bateman SW, Mathews KA, Abrams-Ogg AC, et al. Evaluation of the effect of storage at -70°C for six months on hemostatic function testing in dogs. Can J Vet Res 1999;63:216-220.
60. de Vonne TL, Mouray H. Human alpha2-macroglobulin and its antitrypsin and antithrombin activities in serum and plasma. Clin Chim Acta 1978;90:83-85.
61. Iazbik C, Couto G, Gray TL, et al. Effect of storage conditions on hemostatic parameters of canine plasma obtained for transfusion. Am J Vet Res 2001;62:734-735.
62. Perttila J, Salo M, Peltola O. Plasma fibronectin concentrations in blood products. Intensive Care Med 1990;16:41-43.
63. Stokol T, Parry BW. Stability of canine factor VIII and von Willebrand factor antigen concentration in the frozen state. Res Vet Sci 1995;59:156-159.
64. Wardrop KJ, Brooks MB. Stability of hemostatic proteins in canine fresh frozen plasma units. Vet Clin Pathol 2001;30:91-95.
65. Wardrop KJ, Owen TJ, Meyers KM. Evaluation of an additive solution for preservation of canine red blood cells. J Vet Interm Med 1994;8:253-257.
66. Mincheff M. Changes in donor leukocytes during blood storage. Implications on post-transfusion immunomodulation and transfusion-associated GVHD. Vox Sang 1998;74(suppl 2):189-200.
67. O'Neill EM, Rowley J, Hansson-Wicher M, et al. Effect of 24-hour whole-blood storage on plasma clotting factors. Transfusion 1999;39:488-491.
68. Slichter SJ, Harker LA. Preparation and storage of platelet concentrates. Transfusion 1976;16:8-12.
69. Aaron RK, Beazley RM, Riggle GC. Hematologic integrity after intraoperative autotransfusion. Comparison with bank blood. Arch Surg 1974;108:831-837.
70. Moore EE, Dunn EL, Breslich DJ, et al. Platelet abnormalities associated with massive autotransfusion. J Trauma 1980;20: 1052-1056.
71. Obayashi T, Taniguchi H, Mugitani T, et al. Safety and utility of autologous blood transfusion for resection of metastatic liver tumor. Hepatogastroenterology 2001;48:812-817.
72. Stillman RN, Wrezlewicz WW, Stanczewski B, et al. The haematological hazards of autotransfusion. Bi J Surg 1976;63: 651-654.
73. Smith JE. Erythrocytes. Adv Vet Sci Comp Med 1991;36: 9-55.
74. Young LE, O'Brien WA, Swisher SN, et al. Blood groups in dogs - their significance to the veterinarian. Am J Vet Res 1952;13: 207-213.
75. Young LE, Ervin DM, Yuile CL. Hemolytic reactions produced by dogs by transfusion of incompatible dog blood and plasma. I. Serologic and hematologic aspects. Blood 1949;4: 1218-1231.
76. Knottenbelt CM, Day MJ, Cripps PJ, et al. Measurement of titres of naturally occurring alloantibodies against feline blood group antigens in the UK. J Small Anim Pract 1999;40:365-370.
77. Giger U, Bucheler J. Transfusion of type-A and type-B blood to cats. J Am Vet Med Assoc 1991;198:411-418.
78. Giger U, Gelens CJ, Callan MB. et al. An acute hemolytic transfusion reaction caused by dog crythrocyte antigen 1.1 incompatibility in a previously sensitized dog. J Am Vet Med Assoc 1995; 206:1358-1362.
79. Moon PF. Fluid therapy and blood transfusion. In: Seymour C, Gleed R, eds. BSAVA Manual of small animal anaesthesia and analgesia. Cheltenham, Great Britain: BSAVA, 1999;119-137.
80. Ryden SE, Oberman HA. Compatibility of common intravenous solutions with CPD blood. Transfusion 1975;15:250-255.
81. Blumenthal SR, Williams TC, Barbee RW, et al. Effects of citrated whole blood transfusion in response to hemorrhage. Lab Anim Sci 1999;49:411-417.
82. Olinger GN, Hottenrott C, Mulder DG, et al. Acute clinical hypocalcemic myocardial depression during rapid blood transfusion and post operative hemodialysis: a preventable complication. J Thorac Cardiovasc Surg 1976;72:503-511.
83. Cote' CJ. Depth of halothane anesthesia potentiates citrate-induced ionized hypocalcemia and adverse cardiovascular events in dogs. Anesthesiol 1987;67:676-680.
84. Creteur J, Sibbald W, Vincent JL. Hemoglobin solutions - not just red blood cell substitutes. Crit Care Med 2000;28: 3025-3034.
85. Ketcham EM, Cairns CB. Hemoglobin-based oxygen carriers: development and clinical potential. Ann Emerg Med 1999;33: 326-337.
86. Messmer K, Jesch F, Schaff J, et al. Oxygen supply by stroma-free hemoglobin. Prog Clin Biol Res 1978;19:175-190.
87. Tremper KK, Friedman AE, Levine EM, et al. The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA. N Engl J Med 1982;307: 277-283.
88. Usaba A, Osuka F, Kimura T, et al. Liposome encapsulated hemoglobin as a resuscitation fluid for hemorrhagic shock. Artif Organs 1998;22:116-122.
89. Baron JF. Haemoglobin therapy in clinical practice: use and characteristics of DCLHb. Br J Anaesth 1998;81 (suppl 1):34-37.
90. Lee JT Jr, Ahrenholz DH, Nelson RD, et al. Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. V. The significance of the coordinated iron component. Surgery 1979;86: 41-48.
91. Lee R, Atsumi N, Jacobs EE Jr, et al. Ultrapure, stroma-free, polymerized bovine hemoglobin solution: evaluation of renal toxicity. J Surg Res 1989;47:407-411.
92. Motterlini R, Foresti R, Vandegriff K, et al. Oxidative-stress response in vascular endothelial cells exposed to acellular hemoglobin solutions. Am J Physiol 1995;269:H648-H655.
93. Motterlini R, Macdonald WW. Cell-free hemoglobin potentiates acetylcholine-induced coronary vasoconstriction in rabbit hearts. J Appl Physiol 1993;75:2224-2233.
94. Olsen SB, Tang DB, Jackson MR, et al. Enhancement of platelet deposition by cross-linked hemoglobin in a rat carotid endarterectomy model. Circulation 1996;93:327-332.
95. Sharma AC, Gulati A. Yohimbine modulates diaspirin crosslinked hemoglobin-induced systemic hemodynamics and regional circulatory effects. Crit Care Med 1995;23:874-884.
96. Moss GS, Gould SA, Sehgal LR, et al. Hemoglobin solution - from tetramer to polymer. Surgery 1984;95:249-255.
97. 2 carrier. J Truama 1986;26: 903-908.
98. Ali AA, Ali GS, Steinke JM, et al. Co-oximetry interference by hemoglobin-based blood substitutes. Anesth Analg 2001;92: 863-869.
99. Phillips SL, Polzin DJ. Clinical disorders of potassium homeostasis. Hyperkalemia and hypokalemia. Vet Clin North Am Small Anim Pract 1998;28:545-564.
100. Schwartz WB, Orning KJ, Porter R. The internal distribution of hydrogen ions with varying degrees of metabolic acidosis. J Clin Invest 1957;36:373-382.
101. Schenck PA, Chew DJ, Brooks CL. Fractionation of canine serum calcium, using a micropartition system. Am J Vet Res 1996;57: 268-271.
102. Ladenson JH, Lewis JW, Boyd JC. Failure of total calcium corrected for protein, albumin, and pH to correctly assess free calcium status. J Clin Endocrinol Metab 1978;46:986-993.
103. Schenck PA, Chew DJ, Brooks CL. Effects of storage on serum ionized calcium and pH values in clinically normal dogs. Am J Vet Res 1995;56:304-307.
104. Lyon ME, Guajardo M, Laha T, et al. Zinc heparin introduces a preanalytical error in the measurement of ionized calcium concentration. Stand J Clin Lab Invest 1995;55:61-65.
105. Rosol TJ, Chew DJ, Nagode LA, et al. Disorders of calcium. Hypercalcemia and hypocalcemia. In: DiBartola SP, ed. Fluid therapy in small animal practice. 2nd ed. Philadelphia: WB Saunders Co, 2000;108-162.
106. Shils ME. Magnesium, calcium and parathyroid interactions. Ann N Y Acad Sci 1980;355:165-180.
107. Martin LG, Matteson VL, Wingfield WE, et al. Abnormalities of serum magnesium in critically ill dogs: incidence and implications. J Vet Emerg Crit Care 1994;4:15-20.
108. Khanna C, Lund EM, Raffe M, et al. Hypomagnesemia in 188 dogs: a hospital population-based prevalence study. J Vet Intern Med 1998;12:304-309.
109. Flatman PW, Lew VL. The magnesium dependence of sodium-pump-mediated sodium-potassium and sodium-sodium exchange in intact human red cells. J Physiol 1981;315:421-446.
110. Martin HE. Clinical magnesium deficiency. Ann N Y Acad Sci 1969;162:891-900.
111. Banai S, Tzivoni D. Drug therapy for torsades de pointes. J Cardiovasc Electrophysiol 1993;4:206-210.
112. Baraka A, Ayoub C, Kawkabani N. Magnesium therapy for refractory ventricular fibrillation. J Cardiothorac Vasc Anesth 2000;14: 196-199.
113. Brodsky MA, Orlov MV, Capparelli EV, et al. Magnesium therapy in new-onset atrial fibrillation. Am J Cardiol 1994;73:1227-1229.
114. Iseri LT, Fairshter RD, Hardemann JL, et al. Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J 1985;110:789-794.
115. Tramer MR, Schneider J, Marti RA, et al. Role of magnesium sulfate in postoperative analgesia. Anesthesiology 1996;84:340-347.
116. Dhupa N, Proulx J. Hypocalcemia and hypomagnesemia. Vet Clin North Am Small Anim Pract 1998;28:587-608.
117. Elin RJ. Magnesium: the fifth but forgotten electrolyte. Am J Clin Pathol 1994;102:616-622.
118. Nakayama T, Nakayama H, Miyamolo M, et al. Hemodynamic and electrocardiographic effects of magnesium sulfate in healthy dogs. J Vet Intern Med 1999;13:485-490.
119. Bowen JM, Blackmon DM, Heavner JE. Effect of magnesium ions on neuromuscular transmission in the horse, steer, and dog. J Am Vet Med Assoc 1970;157:164-173.
120. Whang R, Whang DD, Ryan MP Refractory potassium repletion. A consequence of magnesium deficiency. Arch Intern Med 1992;152:40-45.
121. Nakatani T, Yasuda K, Ozawa K. Hyperglycemic hyperosmolar nonketotic dehydration in relation to blood ketone body ratio in partially hepatectomized rabbits. Am J Surg 1988;155:559-563.